135 related articles for article (PubMed ID: 21157628)
1. Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.
Seixas FK; Borsuk S; Fagundes MQ; Hartwig DD; Da Silva EF; Cerqueira GM; Dellagostin OA
Biol Res; 2010; 43(1):13-8. PubMed ID: 21157628
[TBL] [Abstract][Full Text] [Related]
2. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge.
Seixas FK; da Silva EF; Hartwig DD; Cerqueira GM; Amaral M; Fagundes MQ; Dossa RG; Dellagostin OA
Vaccine; 2007 Dec; 26(1):88-95. PubMed ID: 18063449
[TBL] [Abstract][Full Text] [Related]
4. Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin.
Rizzi C; Peiter AC; Oliveira TL; Seixas AC; Leal KS; Hartwig DD; Seixas FK; Borsuk S; Dellagostin OA
Mem Inst Oswaldo Cruz; 2017 Feb; 112(2):123-130. PubMed ID: 28177046
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Mycobacterium bovis BCG.
Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
[TBL] [Abstract][Full Text] [Related]
6. [Construction and expression of recombinant Mycobacterium bovis BCG with the ompA-like membrane protein gene Loa22 of Leptospira interrogans serovar].
Li DK; Bao L; Zhang Y; Sun Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):189-93. PubMed ID: 20506632
[TBL] [Abstract][Full Text] [Related]
7. Protection against leptospirosis conferred by Mycobacterium bovis BCG expressing antigens from Leptospira interrogans.
Dorneles J; Madruga AB; Seixas Neto ACP; Rizzi C; Bettin ÉB; Hecktheuer AS; Castro CC; Fernandes CG; Oliveira TL; Dellagostin OA
Vaccine; 2020 Dec; 38(51):8136-8144. PubMed ID: 33176938
[TBL] [Abstract][Full Text] [Related]
8. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
Fuerst TR; Stover CK; de la Cruz VF
Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
[TBL] [Abstract][Full Text] [Related]
9. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
DasGupta SK; Jain S; Kaushal D; Tyagi AK
Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
[TBL] [Abstract][Full Text] [Related]
10. Preclinical development of BCG.HIVA
Mahant A; Saubi N; Eto Y; Guitart N; Gatell JM; Hanke T; Joseph J
Hum Vaccin Immunother; 2017 Aug; 13(8):1798-1810. PubMed ID: 28426273
[TBL] [Abstract][Full Text] [Related]
11. Transformation of BCG with plasmid DNA.
Lugosi L; Jacobs W; Bloom BR
Acta Leprol; 1989; 7 Suppl 1():256-7. PubMed ID: 2503999
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
[TBL] [Abstract][Full Text] [Related]
13. Recombinant BCG as an antigen delivery system.
Flynn JL
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
[TBL] [Abstract][Full Text] [Related]
14. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
Dai W; Huangfu Y; Zheng B
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity elicited by rBCG vaccines.
Stover CK; Bansal GP; Langerman S; Hanson MS
Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen.
Michelon A; Conceição FR; Binsfeld PC; da Cunha CW; Moreira AN; Argondizzo AP; McIntosh D; Armôa GR; Campos AS; Farber M; McFadden J; Dellagostin OA
Vaccine; 2006 Sep; 24(37-39):6332-9. PubMed ID: 16781025
[TBL] [Abstract][Full Text] [Related]
17. Advances in the development of bacterial vector technology.
Kochi SK; Killeen KP; Ryan US
Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
[TBL] [Abstract][Full Text] [Related]
18. [Construction of the eukaryotic recombinant vector and expression of the outer membrane protein LipL32 gene from Leptospira serovar Lai].
Huang B; Bao L; Zhong Q; Shang ZL; Zhang HD; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Feb; 24(2):109-12. PubMed ID: 18237522
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge.
Wang Q; Li J; Zhang X; Liu Q; Liu C; Ma G; Cao L; Gong P; Cai Y; Zhang G
Vet Parasitol; 2009 Mar; 160(3-4):198-203. PubMed ID: 19117681
[TBL] [Abstract][Full Text] [Related]
20. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.
Nascimento IP; Dias WO; Quintilio W; Hsu T; Jacobs WR; Leite LC
Vaccine; 2009 Dec; 27(52):7346-51. PubMed ID: 19782111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
